Cite
Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase.
MLA
Colombo, Riccardo, et al. “Targeting the Mitotic Checkpoint for Cancer Therapy with NMS-P715, an Inhibitor of MPS1 Kinase.” Cancer Research, vol. 70, no. 24, Dec. 2010, pp. 10255–64. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-10-2101.
APA
Colombo, R., Caldarelli, M., Mennecozzi, M., Giorgini, M. L., Sola, F., Cappella, P., Perrera, C., Depaolini, S. R., Rusconi, L., Cucchi, U., Avanzi, N., Bertrand, J. A., Bossi, R. T., Pesenti, E., Galvani, A., Isacchi, A., Colotta, F., Donati, D., & Moll, J. (2010). Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase. Cancer Research, 70(24), 10255–10264. https://doi.org/10.1158/0008-5472.CAN-10-2101
Chicago
Colombo, Riccardo, Marina Caldarelli, Milena Mennecozzi, Maria Laura Giorgini, Francesco Sola, Paolo Cappella, Claudia Perrera, et al. 2010. “Targeting the Mitotic Checkpoint for Cancer Therapy with NMS-P715, an Inhibitor of MPS1 Kinase.” Cancer Research 70 (24): 10255–64. doi:10.1158/0008-5472.CAN-10-2101.